Korber

Assembly Line

Körber and KKR announce the strategic acquisition of MercuryGate to strengthen their supply chain software business

📅 Date:

🔖 Topics: Acquisition

🏢 Organizations: Korber, MercuryGate, KKR


Körber Supply Chain Software, a joint venture between Körber AG and KKR, and leader in end-to-end supply chain software solutions, signed a binding agreement to acquire MercuryGate International Inc., a leading provider of transportation management systems (TMS). MercuryGate is known for its strong capabilities in multimodal optimization and execution, as well as its expertise and capabilities in driving rapid implementation and time to value. The acquisition is a strategic move that extends Körber Supply Chain Software’s capabilities in delivering a comprehensive, innovative, adaptable and scalable supply chain execution portfolio.

The acquisition of MercuryGate will establish a critical pillar of Körber’s ambition to create a unified supply chain execution suite that can offer real-time optimization and collaboration across the supply chain. Customers will benefit from integrated processes across functions, faster and more accurate decision-making and the ability to mitigate risks and disruptions more effectively.

Read more at Koerber Press

How Augmented Reality Strengthens Biotech Manufacturing

📅 Date:

✍️ Author: Carlos de Rojas

🔖 Topics: Augmented Reality

🏭 Vertical: Medical Equipment

🏢 Organizations: Apprentice, Korber


Probably, the biggest advantage of AR is it enables seeing the production process virtually, without the need to be there. “It’s a game-changer for the industry. Individuals can have eyes and ears on site at a moment’s notice to address an emerging issue, or to host routine remote collaboration sessions,” Stracquatanio highlights.

AR can also increase control over the manufacturing process. Pharma and biotech companies cannot afford mistakes during the production phase. A little oversight might lead to serious consequences such as having to start from scratch, which can be very expensive and time-consuming. A recent example is that of Johnson & Johnson’s manufacturing partner Emergent BioSolutions, whose workers erroneously mixed ingredients from two different Covid-19 vaccines; this led to wasting around 15 million vaccine doses.

During a working day, we could see an operator who loads 3D models of biotech instruments, looking at specific pieces and relevant information appearing in the smart glasses or tablet. Meanwhile, another engineer walks up to a machine with a QR code, and instructions pop up in the glasses, facilitating access to the adjustments. A few steps from there, another colleague is looking at batch records, saving values into the system just via voice.

Read more at Labiotech